oxaliplatin (Fresenius Kabi USA, LLC)
Welcome to the PulseAid listing for the oxaliplatin drug offered from Fresenius Kabi USA, LLC. This Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Fresenius Kabi USA, LLC |
NON-PROPRIETARY NAME: | oxaliplatin |
SUBSTANCE NAME: | OXALIPLATIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-06-11 |
END MARKETING DATE: | 0000-00-00 |
oxaliplatin HUMAN PRESCRIPTION DRUG Details:
Item Description | oxaliplatin from Fresenius Kabi USA, LLC |
LABELER NAME: | Fresenius Kabi USA, LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/mL) |
START MARKETING DATE: | 2010-06-11 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 63323-750_1e637855-7c4f-478d-8880-78e0da3cf9d5 |
PRODUCT NDC: | 63323-750 |
APPLICATION NUMBER: | ANDA078811 |
Other OXALIPLATIN Pharmaceutical Manufacturers / Labelers: